The FDA has classified a recall of GEM Premier 5000 PAK cartridges (Part No. 00055407510) as Class II, indicating that use of or exposure to a defective product may cause adverse health consequences that are temporary or medically reversible. The issue stems from customer complaints reporting an increased incidence of 'Process Control Solution Not Detected' (PCSND) errors during warm-up, leading to GEM PAK ejection. This recall impacts worldwide distribution, including the United States and several other countries.

Manufacturers and distributors must ensure compliance with recall procedures. Healthcare providers using the GEM Premier 5000 system should be aware of this potential issue and follow manufacturer guidance for cartridge replacement and error management. While specific compliance deadlines are not detailed, prompt action to address the recall is expected to mitigate risks to patient care and ensure product integrity. Non-compliance with recall directives can lead to further regulatory action.